• FDA
    Cataract/Anterior Segment, Comprehensive Ophthalmology, Cornea/External Disease, Glaucoma, Neuro-Ophthalmology/Orbit, Ocular Pathology/Oncology, Oculoplastics/Orbit, Pediatric Ophth/Strabismus, Refractive Mgmt/Intervention, Retina/Vitreous, Uveitis

    Vital Rx, Inc. d/b/a Atlantic Pharmacy and Compounding is voluntarily recalling all lots of its compounded injectable prescription medications due to lack of sterility assurance.

    The recall, which is being conducted with the knowledge of the FDA, involves medications that are packaged in sterile vials for injection.

    The company will be notifying its patients by mail, and is requesting that all lots of compounded injectable prescription medications be destroyed immediately upon receipt of the notification. Patients should contact their physician or healthcare provider if they have experienced any problems related to taking or using this drug product.

    Physicians and patients can report adverse reactions or quality issues by 2 methods:

    Online: Report adverse reactions or quality problems to the FDA’s MedWatch Adverse Event Reporting.  

    Mail or faxDownload the reporting form or call 1-800-332-1088 to request one, and then complete and return to the address on the pre-addressed form or submit by fax to 1-800-FDA-0178.